PUFA, genotypes and risk for cardiovascular disease

被引:28
|
作者
Panda, Chinmayee [1 ,2 ,3 ]
Varadharaj, Saradhadevi [3 ]
Voruganti, Venkata Saroja [1 ,2 ]
机构
[1] Univ North Carolina Chapel Hill, Dept Nutr, Rm 3150,500 Laureate Way, Kannapolis, NC 28081 USA
[2] Univ North Carolina Chapel Hill, Nutr Res Inst, Rm 3150,500 Laureate Way, Kannapolis, NC 28081 USA
[3] Stand Proc Inc, Palmyra, WI USA
关键词
Genetic variants; Diet; Obesity; Cardiovascular disease; Inflammation; Oxidative stress; POLYUNSATURATED FATTY-ACIDS; FISH-OIL SUPPLEMENTATION; FADS1-FADS2; GENE-CLUSTER; ALPHA-LINOLENIC ACID; INSULIN-RESISTANCE; OMEGA-3-FATTY-ACIDS SUPPLEMENTATION; MYOCARDIAL-INFARCTION; REINFARCTION TRIAL; METABOLIC SYNDROME; ARACHIDONIC-ACID;
D O I
10.1016/j.plefa.2021.102377
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polyunsaturated fatty acids (PUFAs) are long chain fatty acids that are characterized by the presence of more than one double bond. These include fatty acids such as omega-3-alpha-linolenic acid (ALA) and omega-6 -linoleic acid (LA) which can only be obtained from dietary sources and are therefore termed essential fatty acids. They contain the building blocks for dihomo-gamma-linolenic acid and arachidonic acid in the omega-6 family as well as eicosapentaenoic acid and docosahexaenoic acid in the omega-3 family. Both ALA and LA are important constituents of animal and plant cell membranes and are important components of anti-inflammatory and pro-inflammatory hormones and therefore, often modulate cellular immunity under chronic inflammatory states. The variation in physiological PUFA levels is under significant genetic influence, the fatty acid desaturase (FADS) genes being key regulators of PUFA metabolism. These genetic variants have been shown to alter fatty acid metabolism and influence the onset and progression of various metabolic conditions. This detailed review discusses the role of PUFAs, diet and genotypes in risk for cardiovascular diseases.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Religion and cardiovascular disease risk
    Lapane, KL
    Lasater, TM
    Allan, C
    Carleton, RA
    JOURNAL OF RELIGION & HEALTH, 1997, 36 (02): : 155 - 163
  • [32] Risk factors for cardiovascular disease
    Lippi, G
    Guidi, G
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2002, 166 (06) : 710 - 710
  • [33] Sortilin and the risk of cardiovascular disease
    Coutinho, Maria Francisca
    Bourbon, Mafalda
    Prata, Maria Joao
    Alves, Sandra
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2013, 32 (10) : 793 - 799
  • [34] Obesity and cardiovascular disease risk
    Donfrancesco, C.
    Palmieri, L.
    Panico, S.
    Vanuzzo, D.
    Cesana, G.
    Ferrario, M.
    Pilotto, L.
    Giampaoli, S.
    EUROPEAN HEART JOURNAL, 2005, 26 : 681 - 682
  • [35] Testosterone and cardiovascular disease risk
    Yeap, Bu B.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2015, 22 (03) : 193 - 202
  • [36] Homocysteine and risk of cardiovascular disease
    Andreotti, F
    Burzotta, F
    Manzoli, A
    Robinson, K
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2000, 9 (01) : 13 - 21
  • [37] Homocysteine and Risk of Cardiovascular Disease
    Felicita Andreotti
    Francesco Burzotta
    Alessandro Manzoli
    Killian Robinson
    Journal of Thrombosis and Thrombolysis, 2000, 9 : 13 - 21
  • [38] Nephrolithiasis and the risk of cardiovascular disease
    Eisner, Brian H.
    Cooperberg, Matthew R.
    Curhan, Gary C.
    Stoller, Marshall L.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 449 - 449
  • [39] Cardiovascular Disease and Risk Management
    不详
    DIABETES CARE, 2015, 38 : S49 - S57
  • [40] Methotrexate and Risk of Cardiovascular Disease
    Almalag, Haya M.
    Mangoni, Arduino A.
    Crilly, Michael A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (09): : 1383 - 1384